Dr Michael Leach

  • Honorary Clinical Senior Lecturer (School of Medicine, Dentistry & Nursing)

email: Michael.Leach@glasgow.ac.uk

Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Shelley Road, Glasgow, G12 0YN

Import to contacts

Publications

List by: Type | Date

Jump to: 2014 | 2013 | 2012 | 2011 | 2007 | 2006 | 2005 | 2004 | 2002
Number of items: 15.

2014

Hamilton, R., Andrews, I., McKay, P. and Leach, M. (2014) Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography–computed tomography era: a West of Scotland study. Leukemia and Lymphoma, 55(5), pp. 1049-1052. (doi: 10.3109/10428194.2013.821201)

2013

McIlwaine, K. and Leach, M. T. J. (2013) Clostridium perfringens septicaemia. British Journal of Haematology, 163(5), p. 549. (doi: 10.1111/bjh.12551)

Cosimo, E. et al. (2013) Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes pro-survival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Clinical Cancer Research, 19(9), pp. 2393-2405. (doi: 10.1158/1078-0432.CCR-12-2170)

McIlwaine, L., Parker, A., Sandilands, G., Gallipoli, P. and Leach, M. (2013) Neutrophil-specific granule deficiency. British Journal of Haematology, 160(6), p. 735. (doi: 10.1111/bjh.12207)

2012

McKay, P., Leach, M., Jackson, R., Cook, G. and Rule, S. (2012) Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology, 159(4), pp. 405-426. (doi: 10.1111/bjh.12046)

2011

Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)

2007

Gallipoli, P. and Leach, M. (2007) Gingival infiltration in acute monoblastic leukaemia. British Dental Journal, 203(9), pp. 507-509.

Melbourne, A., Atkinson, D., White, M., Collins, D., Leach, M. and Hawkes, D. (2007) Registration of dynamic contrast-enhanced MRI using a progressive principal component registration (PPCR). Physics in Medicine and Biology, 52(17), pp. 5147-5156.

2006

Gordon, W. and Leach, M. (2006) Lung carcinoma with anti-Hu paraneoplastic syndrome. New England Journal of Medicine, 355(5), E4-E4.

Hughes, M. and Leach, M. (2006) Dietary folate deficiency and bilateral retinal haemorrhages. Lancet, 368(9553), p. 2155.

2005

Moreton, P. et al. (2005) Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. Journal of Clinical Oncology, 23(13), pp. 2971-2979.

O'Donnell, A. et al. (2005) A phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. British Journal of Cancer, 93(8), pp. 876-883.

2004

Fragoso, M., Love, P., Verhaegen, F., Nalder, C., Bidmead, A., Leach, M. and Webb, S. (2004) The dose distribution of low dose rate Cs-137 in intracavitary brachytherapy: comparison of Monte Carlo simulation, treatment planning calculation and polymer gel measurement. Physics in Medicine and Biology, 49(24), pp. 5459-5474.

Hale, G. et al. (2004) Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood, 104(4), pp. 948-955.

2002

Leach, M. (2002) Retinal hemorrhages in acute leukemia. New England Journal of Medicine, 346(23), E6-E6.

This list was generated on Sat Apr 13 13:47:52 2024 BST.
Jump to: Articles
Number of items: 15.

Articles

Hamilton, R., Andrews, I., McKay, P. and Leach, M. (2014) Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography–computed tomography era: a West of Scotland study. Leukemia and Lymphoma, 55(5), pp. 1049-1052. (doi: 10.3109/10428194.2013.821201)

McIlwaine, K. and Leach, M. T. J. (2013) Clostridium perfringens septicaemia. British Journal of Haematology, 163(5), p. 549. (doi: 10.1111/bjh.12551)

Cosimo, E. et al. (2013) Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes pro-survival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Clinical Cancer Research, 19(9), pp. 2393-2405. (doi: 10.1158/1078-0432.CCR-12-2170)

McIlwaine, L., Parker, A., Sandilands, G., Gallipoli, P. and Leach, M. (2013) Neutrophil-specific granule deficiency. British Journal of Haematology, 160(6), p. 735. (doi: 10.1111/bjh.12207)

McKay, P., Leach, M., Jackson, R., Cook, G. and Rule, S. (2012) Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology, 159(4), pp. 405-426. (doi: 10.1111/bjh.12046)

Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)

Gallipoli, P. and Leach, M. (2007) Gingival infiltration in acute monoblastic leukaemia. British Dental Journal, 203(9), pp. 507-509.

Melbourne, A., Atkinson, D., White, M., Collins, D., Leach, M. and Hawkes, D. (2007) Registration of dynamic contrast-enhanced MRI using a progressive principal component registration (PPCR). Physics in Medicine and Biology, 52(17), pp. 5147-5156.

Gordon, W. and Leach, M. (2006) Lung carcinoma with anti-Hu paraneoplastic syndrome. New England Journal of Medicine, 355(5), E4-E4.

Hughes, M. and Leach, M. (2006) Dietary folate deficiency and bilateral retinal haemorrhages. Lancet, 368(9553), p. 2155.

Moreton, P. et al. (2005) Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. Journal of Clinical Oncology, 23(13), pp. 2971-2979.

O'Donnell, A. et al. (2005) A phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. British Journal of Cancer, 93(8), pp. 876-883.

Fragoso, M., Love, P., Verhaegen, F., Nalder, C., Bidmead, A., Leach, M. and Webb, S. (2004) The dose distribution of low dose rate Cs-137 in intracavitary brachytherapy: comparison of Monte Carlo simulation, treatment planning calculation and polymer gel measurement. Physics in Medicine and Biology, 49(24), pp. 5459-5474.

Hale, G. et al. (2004) Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood, 104(4), pp. 948-955.

Leach, M. (2002) Retinal hemorrhages in acute leukemia. New England Journal of Medicine, 346(23), E6-E6.

This list was generated on Sat Apr 13 13:47:52 2024 BST.